47
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report

, , , , , , & show all
Pages 1303-1307 | Received 14 Nov 2023, Accepted 23 Mar 2024, Published online: 29 Mar 2024

References

  • Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive Care. 2015;3:48. doi:10.1186/s40560-015-0112-5
  • Endo A, Shiraishi A, Aiboshi J, Hayashi Y, Otomo Y. A case of purpura fulminans caused by Hemophilus influenzae complicated by reversible cardiomyopathy. J Intensive Care. 2014;2(1):13. doi:10.1186/2052-0492-2-13
  • Lin AN, Shaikh A, Lin S, Misra D. A reminder of Escherichia coli sepsis-induced reversible cardiomyopathy. BMJ Case Rep. 2017;2017:bcr–2017. doi:10.1136/bcr-2017-220556
  • Fujioka M, Suzuki K, Iwashita Y, et al. Influenza-associated septic shock accompanied by septic cardiomyopathy that developed in summer and mimicked fulminant myocarditis. Acute medicine & surgery. Apr. 2019;6(2):192–196. doi:10.1002/ams2.394
  • Lee SI, Hwang HJ, Lee SY, et al. Veno-veno-arterial extracorporeal membrane oxygenation for acute respiratory distress syndrome with septic-induced cardiomyopathy due to severe pulmonary tuberculosis. J Artif Organs. 2017;20(4):359–364. doi:10.1007/s10047-017-0982-5
  • Guo S, Guo Q. Syphilis-associated septic cardiomyopathy: case report and review of the literature. BMC Infect Dis. 2021;21(1):33. doi:10.1186/s12879-020-05722-z
  • Ehrman RR, Sullivan AN, Favot MJ, et al. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Critical Care. 2018;22(1):1–14. doi:10.1186/s13054-018-2043-8
  • Li Y, Li H, Zhang D. Analysis of incidence and risk factors of septic cardiomyopathy. Chin J Emerg Med. 2019;2019:836–840.
  • Liang YW, Zhu YF, Zhang R, Zhang M, Ye XL, Wei JR. Incidence, prognosis, and risk factors of sepsis-induced cardiomyopathy. World J Clin Cases. 2021;9(31):9452–9468. doi:10.12998/wjcc.v9.i31.9452
  • Ravikumar N, Sayed MA, Poonsuph CJ, Sehgal R, Shirke MM, Harky A. Septic cardiomyopathy: from basics to management choices. Curr Prob Cardiol. 2021;46(4):100767. doi:10.1016/j.cpcardiol.2020.100767
  • Gu X, Hua Y-H, Zhang Y-D, Bao D, Lv J, Hu H-F. The pathogenesis of, host defense mechanisms, and the development of AFMP4 antigen as a vaccine. Pol J Microbiol. 2021;70(1):3–11. doi:10.33073/pjm-2021-003
  • Waring P, Eichner RD, Müllbacher A, Sjaarda A. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem. 1988;263(34):18493–18499. doi:10.1016/S0021-9258(19)81385-6
  • Vandewoude KH, Blot SI, Depuydt P, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Critical Care. 2006;10(1):1–10. doi:10.1186/cc4823
  • Liu C, Zhu R, Zhou Z, et al. Sepsis-induced cardiomyopathy complicated with cardiogenic shock patients supported with extracorporeal membrane oxygenation. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017;29(12):1140–1143. doi:10.3760/cma.j.issn.2095-4352.2017.12.018
  • Vogel DJ, Murray J, Czapran AZ, et al. Veno-arterio-venous ECMO for septic cardiomyopathy: a single-centre experience. Perfusion. 2018;33(1_suppl):57–64. doi:10.1177/0267659118766833
  • Takahashi Y, Sonoo T, Naraba H, Hashimoto H, Nakamura K. Effect of intra-arterial balloon pumping for refractory septic cardiomyopathy: a case series. Indian J Crit Care Med. 2019;23(4):182. doi:10.5005/jp-journals-10071-23150